Eric K. Richfield

Overview

Best Publications

• Neuronal localization of cannabinoid receptors in the basal ganglia of the rat

  M Herkenham;A B Lynn;B R de Costa;E K Richfield

  656
  Citations

• The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.

  Mona J. Thiruchelvam;Eric K Richfield;Raymond B Baggs;Arnold W. Tank

  574
  Citations

• Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system.

  Eric K. Richfield;John B. Penney;Anne B. Young

  559
  Citations

• Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease?

  M Thiruchelvam;B.J Brockel;E.K Richfield;R.B Baggs

  383
  Citations

• Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype.

  Mona Thiruchelvam;Alison McCormack;Eric K. Richfield;Raymond B. Baggs

  363
  Citations

• Behavioral and neurochemical effects of wild-type and mutated human α-synuclein in transgenic mice

  Eric K. Richfield;Mona J. Thiruchelvam;Deborah A. Cory-Slechta;Charles Wuertzer

  351
  Citations

• Comparative distribution of dopamine D-1 and D-2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys.

  Eric K. Richfield;Anne B. Young;John B. Penney

  321
  Citations

• DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions

  L B Thomas;D J Gates;E K Richfield;T F O'Brien

  291
  Citations

• Developmental Exposure to the Pesticides Paraquat and Maneb and the Parkinson’s Disease Phenotype

  Mona Thiruchelvam;Eric K. Richfield;Becky M. Goodman;Raymond B. Baggs

  270
  Citations

• Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus.

  Eric K. Richfield;Miles Herkenham

  199
  Citations

• Risk factors for dopaminergic neuron loss in human alpha-synuclein transgenic mice.

  M. J. Thiruchelvam;J. M. Powers;D. A. Cory-Slechta;E. K. Richfield

  197
  Citations

• The gestational environment and Parkinson's disease: evidence for neurodevelopmental origins of a neurodegenerative disorder.

  Brian K Barlow;Deborah A Cory-Slechta;Deborah A Cory-Slechta;Eric K Richfield;Mona Thiruchelvam;Mona Thiruchelvam

  194
  Citations

• Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients

  Eric K. Richfield;Kathleen A. Maguire-Zeiss;Harald E. Vonkeman;Pieter Voorn;Pieter Voorn

  177
  Citations

• Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis

  Deborah J. Stumpo;Hal E. Broxmeyer;Toni Ward;Scott Cooper

  166
  Citations

• Comparative distributions of dopamine D-1 and D-2 receptors in the cerebral cortex of rats, cats, and monkeys

  Eric K. Richfield;Anne B. Young;John B. Penney

  159
  Citations

• Developmental Pesticide Models of the Parkinson Disease Phenotype

  Deborah A. Cory-Slechta;Mona Thiruchelvam;Brian K. Barlow;Eric K. Richfield

  155
  Citations

• Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum.

  M. Herkenham;B.G.S. Groen;A.B. Lynn;B.R. De Costa

  145
  Citations

• Prolonged toxicokinetics and toxicodynamics of paraquat in mouse brain.

  Kavita Prasad;Bozena Winnik;Mona J. Thiruchelvam;Brian Buckley

  128
  Citations

• Neurological syndrome following bilateral damage to the head of the caudate nuclei.

  Eric K. Richfield;Roy E. Twyman;Stanley Berent

  126
  Citations

• Heterogeneous dopamine receptor changes in early and late Huntington's disease

  Eric K. Richfield;Christopher F. O'Brien;Thomas Eskin;Ira Shoulson

  123
  Citations